Philogen S.p.a.

Cornelia Winter Halin

Dario Neri

Teresa Hemmerle

Silvana Renner

Michael Detmar

Simon Schwager

The application relates to a fusion protein comprising an antibody molecule, or antigen-binding fragment thereof, and a member of the vascular endothelial growth factor family, such as VEGF-C or VEGF-D. The antibody molecule preferably binds an antigen associated with angiogenesis, such as the ED-A isoform of fibronectin. In particular, the application relates to the therapeutic use of such fusion protein in the treatment of an inflammatory disease or disorder.

Growing community of inventors

Zurich, Switzerland

Cornelia Winter Halin